Surge in Open Interest Signals Increased Trading Activity for Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 118,271 contracts, alongside a trading volume of 97,022 contracts. The stock has outperformed its sector and demonstrated consistent gains over the past six days, while maintaining liquidity despite a slight decline in delivery volume.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in its futures market. The latest open interest stands at 118,271 contracts, a notable rise from the previous open interest of 96,370 contracts, marking a change of 21,901 contracts or 22.73%. The trading volume for the day reached 97,022 contracts, indicating robust engagement from market participants.In terms of performance, Sun Pharma has outperformed its sector by 1.06% today, with a 1.27% return on the day. The stock has shown consistent gains over the past six days, accumulating a total return of 3.25% during this period. While the stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average.
Despite a slight decline in delivery volume, which fell by 7.09% against the 5-day average, the stock maintains sufficient liquidity for trades, with a market cap of Rs 4,15,636.80 Cr, categorizing it as a large-cap entity in the Pharmaceuticals & Biotechnology industry. Overall, the increase in open interest and the stock's recent performance highlight a dynamic trading environment for Sun Pharmaceutical Industries.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
